-transparent.png){kind=logo}
Dapagliflozin and Anemia in Patients with Chronic Kidney Disease. 2023
Akihiko Koshino, and
Meir Schechter, and
Glenn M Chertow, and
Priya Vart, and
Niels Jongs, and
Robert D Toto, and
Peter Rossing, and
Ricardo Correa-Rotter, and
John J V McMurray, and
Jose Luis Górriz, and
Rey Isidto, and
Naoki Kashihara, and
Anna Maria Langkilde, and
David C Wheeler, and
Hiddo J L Heerspink
Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
DAPA and Anemia in Patients with CKDThis post hoc analysis of the DAPA-CKD (Dapagliflozin in Patients with Chronic Kidney Disease) trial assessed the impact of dapagliflozin treatment on the correction and prevention of anemia. Results over a 2.4-year median follow-up show that dapagliflozin is associated with increase in hematocrit, correction of anemia, and reduced risk of incident anemia in patients with CKD with or without type 2 diabetes.
Related Publications
Akihiko Koshino, and
Meir Schechter, and
Glenn M Chertow, and
Priya Vart, and
Niels Jongs, and
Robert D Toto, and
Peter Rossing, and
Ricardo Correa-Rotter, and
John J V McMurray, and
Jose Luis Górriz, and
Rey Isidto, and
Naoki Kashihara, and
Anna Maria Langkilde, and
David C Wheeler, and
Hiddo J L Heerspink
October 2020,
The New England journal of medicine,
Akihiko Koshino, and
Meir Schechter, and
Glenn M Chertow, and
Priya Vart, and
Niels Jongs, and
Robert D Toto, and
Peter Rossing, and
Ricardo Correa-Rotter, and
John J V McMurray, and
Jose Luis Górriz, and
Rey Isidto, and
Naoki Kashihara, and
Anna Maria Langkilde, and
David C Wheeler, and
Hiddo J L Heerspink
January 2021,
The New England journal of medicine,
Akihiko Koshino, and
Meir Schechter, and
Glenn M Chertow, and
Priya Vart, and
Niels Jongs, and
Robert D Toto, and
Peter Rossing, and
Ricardo Correa-Rotter, and
John J V McMurray, and
Jose Luis Górriz, and
Rey Isidto, and
Naoki Kashihara, and
Anna Maria Langkilde, and
David C Wheeler, and
Hiddo J L Heerspink
January 2021,
The New England journal of medicine,
Akihiko Koshino, and
Meir Schechter, and
Glenn M Chertow, and
Priya Vart, and
Niels Jongs, and
Robert D Toto, and
Peter Rossing, and
Ricardo Correa-Rotter, and
John J V McMurray, and
Jose Luis Górriz, and
Rey Isidto, and
Naoki Kashihara, and
Anna Maria Langkilde, and
David C Wheeler, and
Hiddo J L Heerspink
January 2021,
The New England journal of medicine,
Akihiko Koshino, and
Meir Schechter, and
Glenn M Chertow, and
Priya Vart, and
Niels Jongs, and
Robert D Toto, and
Peter Rossing, and
Ricardo Correa-Rotter, and
John J V McMurray, and
Jose Luis Górriz, and
Rey Isidto, and
Naoki Kashihara, and
Anna Maria Langkilde, and
David C Wheeler, and
Hiddo J L Heerspink
January 2023,
Frontiers in pharmacology,
Akihiko Koshino, and
Meir Schechter, and
Glenn M Chertow, and
Priya Vart, and
Niels Jongs, and
Robert D Toto, and
Peter Rossing, and
Ricardo Correa-Rotter, and
John J V McMurray, and
Jose Luis Górriz, and
Rey Isidto, and
Naoki Kashihara, and
Anna Maria Langkilde, and
David C Wheeler, and
Hiddo J L Heerspink
August 2023,
Drug and therapeutics bulletin,
Akihiko Koshino, and
Meir Schechter, and
Glenn M Chertow, and
Priya Vart, and
Niels Jongs, and
Robert D Toto, and
Peter Rossing, and
Ricardo Correa-Rotter, and
John J V McMurray, and
Jose Luis Górriz, and
Rey Isidto, and
Naoki Kashihara, and
Anna Maria Langkilde, and
David C Wheeler, and
Hiddo J L Heerspink
April 2024,
American heart journal,
Akihiko Koshino, and
Meir Schechter, and
Glenn M Chertow, and
Priya Vart, and
Niels Jongs, and
Robert D Toto, and
Peter Rossing, and
Ricardo Correa-Rotter, and
John J V McMurray, and
Jose Luis Górriz, and
Rey Isidto, and
Naoki Kashihara, and
Anna Maria Langkilde, and
David C Wheeler, and
Hiddo J L Heerspink
July 2023,
Annals of internal medicine,
Akihiko Koshino, and
Meir Schechter, and
Glenn M Chertow, and
Priya Vart, and
Niels Jongs, and
Robert D Toto, and
Peter Rossing, and
Ricardo Correa-Rotter, and
John J V McMurray, and
Jose Luis Górriz, and
Rey Isidto, and
Naoki Kashihara, and
Anna Maria Langkilde, and
David C Wheeler, and
Hiddo J L Heerspink
July 2023,
Annals of internal medicine,
Akihiko Koshino, and
Meir Schechter, and
Glenn M Chertow, and
Priya Vart, and
Niels Jongs, and
Robert D Toto, and
Peter Rossing, and
Ricardo Correa-Rotter, and
John J V McMurray, and
Jose Luis Górriz, and
Rey Isidto, and
Naoki Kashihara, and
Anna Maria Langkilde, and
David C Wheeler, and
Hiddo J L Heerspink
January 2013,
The New England journal of medicine,
